Ident. | Authors (with country if any) | Title |
---|
000284 (2016) |
Enkhjargal Bayarsaikhan [Corée du Sud, Mongolie] ; Delger Bayarsaikhan [Corée du Sud] ; Jaesuk Lee [Corée du Sud] ; Myeongjoo Son [Corée du Sud] ; Seyeon Oh [Corée du Sud] ; Jeongsik Moon [Corée du Sud] ; Hye-Jeong Park [Corée du Sud] ; Arivazhagan Roshini [Corée du Sud] ; Seung U. Kim [Canada] ; Byoung-Joon Song [États-Unis] ; Seung-Mook Jo [Corée du Sud] ; Kyunghee Byun [Corée du Sud] ; Bonghee Lee [Corée du Sud] | Microglial AGE-albumin is critical for neuronal death in Parkinson’s disease: a possible implication for theranostics |
000488 (2015) |
Janelle Drouin-Ouellet ; Isabelle St-Amour ; Martine Saint-Pierre ; Jérôme Lamontagne-Proulx ; Jasna Kriz ; Roger A. Barker ; Francesca Cicchetti | Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease |
000523 (2015) |
Emily M. Rocha [États-Unis] ; Gaynor A. Smith [États-Unis] ; Eric Park [États-Unis] ; Hongmei Cao [États-Unis] ; Anne-Renee Graham [États-Unis] ; Eilish Brown [États-Unis] ; Jesse R. Mclean [États-Unis] ; Melissa A. Hayes [États-Unis] ; Jonathan Beagan [États-Unis] ; Sarah C. Izen [États-Unis] ; Eduardo Perez-Torres [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis] | Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice. |
000610 (2015) |
Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud] | Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) |
000692 (2015) |
Yuko Koshimori [Canada] ; Ji-Hyun Ko [Canada] ; Romina Mizrahi [Canada] ; Pablo Rusjan [Canada] ; Rostom Mabrouk [Canada] ; Mark F. Jacobs [Canada] ; Leigh Christopher [Canada] ; Clement Hamani [Canada] ; Anthony E. Lang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease |
000843 (2015) |
Dany Arsenault [Canada] ; Janelle Drouin-Ouellet [Royaume-Uni] ; Martine Saint-Pierre [Canada] ; Petros Petrou [Canada] ; Marilyn Dubois [Canada] ; Jasna Kriz [Canada] ; Roger A. Barker [Royaume-Uni] ; Antonio Cicchetti [Canada] ; Francesca Cicchetti [Canada] | A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice |
000A55 (2014) |
Jocelyn M. Madeira [Canada] ; Ekta Bajwa [Canada] ; Maegan J. Stuart [Canada] ; Sadayuki Hashioka [Japon] ; Andis Klegeris [Canada] | Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst. |
000D50 (2013) |
Naomi P. Visanji [Canada] ; Joanna F. Collingwood ; Mary E. Finnegan ; Anurag Tandon ; Emily House ; Lili-Naz Hazrati | Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy. |
000F69 (2013) |
Moonhee Lee [Canada] ; Edith Mcgeer [Canada] ; Ravinder Kodela [États-Unis] ; Khosrow Kashfi [États-Unis] ; Patrick L. Mcgeer [Canada] | NOSH‐aspirin (NBS‐1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: A new candidate for treatment of neurodegenerative disorders |
001571 (2011) |
J P Little [Canada] ; E B Villanueva ; A. Klegeris | Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease. |
001638 (2011) |
Moonhee Lee [Canada] ; Nattinee Jantaratnotai ; Edith Mcgeer ; James G. Mclarnon ; Patrick L. Mcgeer | Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels. |
001C17 (2010) |
Moonhee Lee [Canada] ; Anna Sparatore [Italie] ; Piero Del Soldato [Italie] ; Edith Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation |
001E78 (2009) |
Moonhee Lee [Canada] ; Claudia Schwab ; Sheng Yu ; Edith Mcgeer ; Patrick L. Mcgeer | Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. |
002285 (2008) |
Andis Klegeris [Canada] ; Jane Li [États-Unis] ; Theo K. Bammler [États-Unis] ; Jinghua Jin [États-Unis] ; David Zhu [États-Unis] ; Daniel T. Kashima [États-Unis] ; Sheng Pan [États-Unis] ; Sadayuki Hashioka [Canada] ; John Maguire [Canada] ; Patrick L. Mcgeer [Canada] ; Jing Zhang [États-Unis] | Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP‐1 cell neurotoxicity |
002317 (2008) |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial reactions in Parkinson's disease |
002425 (2007) |
Andis Klegeris [Canada] ; Edith G. Mcgeer ; Patrick L. Mcgeer | Therapeutic approaches to inflammation in neurodegenerative disease. |
002466 (2007) |
Matthew P. Mount [Canada] ; Arman Lira ; David Grimes ; Patrice D. Smith ; Sylvie Faucher ; Ruth Slack ; Hymie Anisman ; Shawn Hayley ; David S. Park | Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. |
002919 (2006) |
Judith Miklossy [Canada] ; Tetsuaki Arai [Japon] ; Jian-Ping Guo [Canada] ; Andis Klegeris [Canada] ; SHENG YU [Canada] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | LRRK2 expression in normal and pathologic human brain and in human cell lines |
002E38 (2003) |
Patrick L. Mcgeer [Canada] ; Claudia Schwab ; Andre Parent [Canada] ; Doris Doudet | Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration |
003030 (2002) |
Yong B. Lee [Canada, Corée du Sud] ; Atsushi Nagai [Canada, Japon] ; Seung U. Kim [Canada, Corée du Sud] | Cytokines, chemokines, and cytokine receptors in human microglia |
003855 (1998) |
P L Mcgeer [Canada] ; E G Mcgeer | Mechanisms of cell death in Alzheimer disease--immunopathology. |